CLDX
Celldex Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$29.67
+7.77%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-42.1%
Return on equity
-38.4%
Return on assets
-45.3%
Return on invested capital
0.00x
Asset turnover
-$235.6M
Cash from operations
$9.14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026